Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Meenal Shukla, PhD, Venkaiah Betapudi, PhD, Ravi Kumar Alluri, PhD, Sergei Merkulov, PhD, James Hale, PhD, Justin Lathia, PhD, Keith R. McCrae, MD

Blood (2016) 128 (22): 1394.

https://doi.org/10.1182/blood.V128.22.1394.1394

Published: 2016

Journal Articles

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Anja Seckinger, MD, Tobias Meißner, PhD, Uta Bertsch, MD, Hans Salwender, MD, Jan Dürig, MD, Mathias Hänel, MD, Igor W. Blau, MD, Christof Scheid, MD, Katja Weisel, MD, Bernard Klein, PhD, Hartmut Goldschmidt, MD, Dirk Hose, Dr. med. dipl.-phys.

Blood (2013) 122 (21): 1863.

https://doi.org/10.1182/blood.V122.21.1863.1863

Published: 2013

Journal Articles

Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma.

Ida Bruun Kristensen, MD, Jacob Haaber, MD, PhD, Maria B Lyng, MSc, PhD, Lise Pedersen, Lars Melholt Rasmussen, Henrik J Ditzel, MD, PhD, Niels Abildgaard, MD

Blood (2012) 120 (21): 2922.

https://doi.org/10.1182/blood.V120.21.2922.2922

Published: 2012

Journal Articles

Expression of Factors in the Hepatocyte Growth Factor (HGF) Pathway in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma

Ida Bruun Kristensen, MD, Jacob Haaber, MD, PhD, Maria B Lyng, MSc, PhD, Lise Pedersen, Lars Melholt Rasmussen, Henrik J Ditzel, MD, PhD, Niels Abildgaard, MD

Blood (2012) 120 (21): 3977.

https://doi.org/10.1182/blood.V120.21.3977.3977

Published: 2012

Journal Articles

Levels of Phosphorylated P70 S6 Kinase and Phosphorylated ERK1&2 Predict Overall Survival and Time to First Treatment In Chronic Lymphocytic Leukaemia

James R Bailey, MD, PhD, Gina L Eagle, PhD, Pointon Jo, Ria Brathwaite, Abbott Jody, Russell Patmore, MD, Paul Evans, PhD, John Greenman, PhD, Lynn Cawkwell, PhD, David J Allsup, MD, PhD

Blood (2010) 116 (21): 1363.

https://doi.org/10.1182/blood.V116.21.1363.1363

Published: 2010

NARROW

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma.

Expression of Factors in the Hepatocyte Growth Factor (HGF) Pathway in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma

Levels of Phosphorylated P70 S6 Kinase and Phosphorylated ERK1&2 Predict Overall Survival and Time to First Treatment In Chronic Lymphocytic Leukaemia

Email alerts

ASH Publications

American Society of Hematology

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma.

Expression of Factors in the Hepatocyte Growth Factor (HGF) Pathway in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma

Levels of Phosphorylated P70 S6 Kinase and Phosphorylated ERK1&2 Predict Overall Survival and Time to First Treatment In Chronic Lymphocytic Leukaemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only